Our study confirmed that the m6A methyltransferase METTL3 participates in the chemoresistance process of SCLC by promoting m6A of DCP2, inducing Pink1-Parkin pathway mediated mitophagy and reducing mitochondrial damage. Here, METTL3 is linked to small cell lung carcinoma.